Arbutus Biopharma Corp (ABUS)
NASDAQ·Healthcare·Biotechnology
$4.46
+2.18%
Mkt Cap $871.14M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
Implied Upside
+90.8%
Consensus $8.50 vs current $4.46
NASDAQ·Healthcare·Biotechnology
$4.46
+2.18%
Mkt Cap $871.14M
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
+90.8%
Consensus $8.50 vs current $4.46